LAROSA JOSEPH J 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Feb 26, 2024
Insider Transaction Report
Form 4
LAROSA JOSEPH J
SVP Gen Counsel and Secretary
Transactions
- Sale
Common Stock
2024-02-22$967.65/sh−1,000$967,650→ 37,543 total
Holdings
- 3,367(indirect: 2022 GRAT)
Common Stock
- 355(indirect: By 401(k))
Common Stock